and speaking of volume and more specifically *trades* ..

New Post Public Reply Private Reply Replies (0) Message Board
4kids 4kids #36993
557
and speaking of volume and more specifically *trades* ..

note B/A just b4 volume undertaken .. approx 1/3 of current *volume* done
just after 10AM .. remember last Friday's *block* trade and ancillary trades
came to 100,300 ... done in approx 16 minutes .. essentially *doubling* Friday's
volume at that point done in 3.5 hours ..

make no mistake folks .. NR is both upside down and requires actual IPIX shares

usually there are only 2 ways to get them .. run a stock up (controlled)
run a stock down .. 52 week low is 63c .. they will if they can .. today's news
on both KITE's acquisition and out of mgmt *imo* continues to add to NRs' stress




VERT 0.725 1,000 09:50
ETRF 0.72 30,000 09:44
NITE 0.72 10,000 09:48
CSTI 0.72 1,000 09:48
CDEL 0.713 1,000 09:57
CANT 0.707 11,000 09:30
PUMA 0.57 1,000 08/24
VNDM 0.57 1,000 08/25
LAFC 0.5362 1,000 08/25
MAXM 0.0001 10,000 07:35



CDEL 0.7349 1,000 09:57
VERT 0.735 1,000 09:55
ETRF 0.74 1,000 09:55
NITE 0.74 1,000 09:56
CANT 0.79 1,000 08:30
PUMA 0.91 1,000 08/24
CSTI 0.91 1,000 09:48
LAFC 0.925 1,000 08/23
VNDM 1.15 100 08/25
MAXM 8.00 100 07:35


note the sequence of trades .. (last round) .. for the CDEL/VERT et al show

1000 + 4000 + 5000 = 10000
10000 + 10000 = 20000
50 signal for 500 (NC)
15 signal for 1500 (NC inverted)
5000 + 1000 + 1000 + 500 + 1000 + 1500 = 10000



10:19:43 0.7199 15 OTO
10:17:17 0.7199 1500 OTO
10:17:17 0.71645 1000 OTO
10:11:26 0.72 1000 OTO
10:11:11 0.7165 500 OTO
10:05:59 0.72 50 OTO
10:03:06 0.72 1000 OTO
10:02:52 0.72 1000 OTO
10:02:35 0.72 5000 OTO
10:02:27 0.72 20000 OTO
10:02:09 0.72 10000 OTO
10:01:54 0.725 1000 OTO
10:01:52 0.72 5000 OTO
09:58:11 0.725 4000 OTO
09:57:08 0.735 737 OTO


bold is my notes in RT ..


Detailed Quote:IPIX (again with the signal and nc)
INNOVATION PHARMACEUTICALS INC
0.7199Down -0.0301 (-4.01 %)AS OF 10:17:17AM ET 08/28/2017
Trade Add to Watch List Set Alert Hypothetical Trade Price History down
CUSIP 45782D100
Last Trade 0.7199
Trade Time 10:17:17am ET
Last Trade Exchange Other OTC
Change -0.0301
% Change -4.01%
Bid 0.713
Bid Size 2000
Bid Exchange OTC Markets
Ask 0.7199
Ask Size 1000
Ask Exchange OTC Markets
Currency USD
Primary Exchange OTC Markets
Index Not In
S&P 500®
DJIA®
NASDAQ 100®
Open 0.715
Day High 0.75
Day Low 0.715
Previous Close
08/25/2017 0.75
52-Week High
11/22/2016 1.505
52-Week Low
05/10/2017 0.63
Price Performance (Last 52 Weeks)
08/25/2017 -45.26%
Volume 99,800
Volume (10 day Average) 115,555
Volume (90 day Average) 253,860




ETRF 0.713 1,000 10:11
CDEL 0.713 1,000 10:11
VERT 0.71 1,000 10:01
CSTI 0.71 1,000 10:02
CANT 0.707 11,000 09:30
NITE 0.70 11,100 10:04
PUMA 0.57 1,000 08/24
VNDM 0.57 1,000 08/25
LAFC 0.5362 1,000 08/25
MAXM 0.0001 10,000 07:35



CDEL 0.7199 1,000 10:11
VERT 0.73 1,000 10:11
ETRF 0.76 2,000 10:03
NITE 0.76 1,000 10:11
CANT 0.79 1,000 08:30
PUMA 0.91 1,000 08/24
CSTI 0.91 1,000 09:48
LAFC 0.925 1,000 08/23
VNDM 1.15 100 08/25
MAXM 8.00 100 07:35




Detailed Quote:IPIX (NC on the uc ask)
INNOVATION PHARMACEUTICALS INC
0.7199Down -0.0301 (-4.01 %)AS OF 10:17:17AM ET 08/28/2017
Trade Add to Watch List Set Alert Hypothetical Trade Price History down
CUSIP 45782D100
Last Trade 0.7199
Trade Time 10:17:17am ET
Last Trade Exchange Other OTC
Change -0.0301
% Change -4.01%
Bid 0.713
Bid Size 2000
Bid Exchange OTC Markets
Ask 0.7199
Ask Size 1000
Ask Exchange OTC Markets
Currency USD
Primary Exchange OTC Markets
Index Not In
S&P 500®
DJIA®
NASDAQ 100®
Open 0.715
Day High 0.75
Day Low 0.715
Previous Close
08/25/2017 0.75
52-Week High
11/22/2016 1.505
52-Week Low
05/10/2017 0.63
Price Performance (Last 52 Weeks)
08/25/2017 -45.26%
Volume 99,785
Volume (10 day Average) 115,555
Volume (90 day Average) 253,860




ETRF 0.713 1,000 10:11
CDEL 0.713 1,000 10:11
VERT 0.71 1,000 10:01
CSTI 0.71 1,000 10:02
CANT 0.707 11,000 09:30
NITE 0.70 11,100 10:04
PUMA 0.57 1,000 08/24
VNDM 0.57 1,000 08/25
LAFC 0.5362 1,000 08/25
MAXM 0.0001 10,000 07:35



CDEL 0.7199 1,000 10:11
VERT 0.73 1,000 10:11
ETRF 0.76 2,000 10:03
NITE 0.76 1,000 10:11
CANT 0.79 1,000 08:30
PUMA 0.91 1,000 08/24
CSTI 0.91 1,000 09:48
LAFC 0.925 1,000 08/23
VNDM 1.15 100 08/25
MAXM 8.00 100 07:35



Detailed Quote:IPIX ( uc on the ask)
INNOVATION PHARMACEUTICALS INC
0.72Down -0.03 (-4.00 %)AS OF 10:11:26AM ET 08/28/2017
Trade Add to Watch List Set Alert Hypothetical Trade Price History down
CUSIP 45782D100
Last Trade 0.72
Trade Time 10:11:26am ET
Last Trade Exchange Other OTC
Change -0.03
% Change -4.00%
Bid 0.713
Bid Size 2000
Bid Exchange OTC Markets
Ask 0.7199
Ask Size 1000
Ask Exchange OTC Markets
Currency USD
Primary Exchange OTC Markets
Index Not In
S&P 500®
DJIA®
NASDAQ 100®
Open 0.715
Day High 0.75
Day Low 0.715
Previous Close
08/25/2017 0.75
52-Week High
11/22/2016 1.505
52-Week Low
05/10/2017 0.63
Price Performance (Last 52 Weeks)
08/25/2017 -45.26%
Volume 97,285
Volume (10 day Average) 115,555
Volume (90 day Average) 253,860




CDEL 0.713 1,000 10:03
ETRF 0.71 2,000 10:02
VERT 0.71 1,000 10:01
CSTI 0.71 1,000 10:02
CANT 0.707 11,000 09:30
NITE 0.70 1,100 10:02
PUMA 0.57 1,000 08/24
VNDM 0.57 1,000 08/25
LAFC 0.5362 1,000 08/25
MAXM 0.0001 10,000 07:35



VERT 0.72 1,000 10:02
NITE 0.735 1,000 10:00
CDEL 0.735 1,000 10:03
ETRF 0.76 2,000 10:03
CANT 0.79 1,000 08:30
PUMA 0.91 1,000 08/24
CSTI 0.91 1,000 09:48
LAFC 0.925 1,000 08/23
VNDM 1.15 100 08/25
MAXM 8.00 100 07
:35



Detailed Quote:IPIX (signal)
INNOVATION PHARMACEUTICALS INC
0.72Down -0.03 (-4.00 %)AS OF 10:03:06AM ET 08/28/2017
Trade Add to Watch List Set Alert Hypothetical Trade Price History down
CUSIP 45782D100
Last Trade 0.72
Trade Time 10:03:06am ET
Last Trade Exchange Other OTC
Change -0.03
% Change -4.00%
Bid 0.713
Bid Size 1000
Bid Exchange OTC Markets
Ask 0.72
Ask Size 1000
Ask Exchange OTC Markets
Currency USD
Primary Exchange OTC Markets
Index Not In
S&P 500®
DJIA®
NASDAQ 100®
Open 0.715
Day High 0.75
Day Low 0.715
Previous Close
08/25/2017 0.75
52-Week High
11/22/2016 1.505
52-Week Low
05/10/2017 0.63
Price Performance (Last 52 Weeks)
08/25/2017 -45.26%
Volume 95,785
Volume (10 day Average) 115,555
Volume (90 day Average) 253,860


btw .. i am no way implying that there aren't legit retail trades in the above mix
this is why i always stress folks should note their time stamps on their respective
trades to see how handled .. and if mirrored and at what PPS (same or reset lower)

4kids


Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bob Evans' Protein Mac & Cheese: Practical Power Play

Updated Category News Views 13

Has anyone else noticed just how fast the world spins when it comes to consumer trends these days? Bob Evans is hopping right on the protein bandwagon with its latest launch, a microwave-ready Protein Macaroni & Cheese that packs 18 grams of protein per serving. You gotta hand it to them for seizing opportunity when they see it. This one's not just about tossing a new...

Continue Reading
Dentistry.One Achieves HITRUST i1, Boosts Cybertrust

Updated Category News Views 2

HITRUST i1 Certification: The Gold Standard in Security For a world increasingly reliant on digital infrastructure, cybersecurity certification is no longer just a badge of honor; it's a cornerstone of trust. Dentistry.One nailed this down by bagging that coveted HITRUST i1 certification. When folks talk about securing data, HITRUST might as well be speaking gospel. We're...

Continue Reading
Pushing for National Liver Cancer Awareness in 2026

Updated Category News Views 6

The Urgency of Liver Cancer Awareness Death doesn’t wait, does it? When liver cancer is the villain in question, every moment becomes precious because this beast doesn’t roar until it’s too late. Here we are in 2026, staring at nearly 31,000 annual deaths in the U.S. alone. But hope flickers with a new congressional resolution aiming to slap a bright spotlight on...

Continue Reading
Truss Financial Tackles Home Equity Closing Delays

Updated Category News Views 8

Truss Financial Group's Bold Move Against Closing Delays In real estate, time is money. Even the most casual market observer could tell you delays can slice through a deal like a hot knife through butter. That's the headache home equity borrowers face, blindsided by closing delays that sneak up on them without warning. An Industry Bottleneck Finally Addressed Enter Truss...

Continue Reading
Cure Blindness Project's 770K Screenings for World Sight Day

Updated Category News Views 5

Visionary Steps Toward a Brighter Future No two words could describe the task that Cure Blindness Project is tackling this year: vision and action. Marking World Sight Day on October 8, they plan to usher in 770,000 eye screenings across Asia, Africa, and the Caribbean. These initiatives aren't just numbers—they're a colossal step toward lifting the veil of avoidable...

Continue Reading
JiMMYBAR! Expands Creatine Market with Target Launch

Updated Category News Views 9

JiMMYBAR! Breaks New Ground in Supplements You ever notice how some companies just know how to shake things up? Take JiMMYBAR!, for instance. The moment I read they’re making moves to get their Creatine + Protein bars into Target stores nationwide, starting October 4, I thought, “That’s one way to drag creatine out from the dusty tub and onto the shelves of...

Continue Reading
Purina Institute Highlights Nutritional Science at WSAVA 2026

Updated Category News Views 7

A Global Stage for Pet Nutrition Science The folks over at the Purina Institute are back in the spotlight as they gear up to throw their weight behind the 51st World Small Animal Veterinary Association (WSAVA) Congress in Warsaw, Poland. Set for October 13-15, 2026, this isn’t just another event—they're bringing some serious clout with their 'Food for Thought'...

Continue Reading
Epic Political Thriller Explores Humanity's Future

Updated Category News Views 3

Adams' Provocative Debut Asks Timeless Questions Sometimes life throws a philosophical curveball, and that's exactly what John C. Adams has done with his debut novel, The Third Phase. This isn't your average political yarn—it's an intricate tapestry intertwining political intrigue, deep spiritual inquiry, and hearty doses of classic philosophy. A Whirlwind Journey...

Continue Reading
Karoo Health Leaps Forward with New CCO Breton

Updated Category News Views 7

Change of Guard in Cardiac Health at Karoo Here's a move that might shake things up in the healthtech sector: Karoo Health just snagged Angela "Angie" Breton as their new Chief Commercial Officer. It's like putting a seasoned captain at the helm right before setting sail on uncharted waters. Breton's not just any captain—she's got a hefty 25 years of experience...

Continue Reading
ROKFORM’s Signal Card: A Wallet Tracker for All

Updated Category News Views 5

The Gadget You Didn't Know You Needed Ever feel that momentary panic when your wallet seems to have vanished into thin air? ROKFORM's fresh offering, the Signal Card, tackles that heart-stopping moment head-on. They've taken the mundane act of misplacing your wallet and transformed it with their sleek, credit-card-sized tracker. This baby pairs seamlessly with Apple Find...

Continue Reading

Top 5 Most Recently Viewed Articles

Update on Victoria’s Secret & Co.'s Q1 2025 Financial Outlook

Updated Category News Views 357

Introduction to Victoria's Secret & Co. Victoria’s Secret & Co. continues to be a recognizable name in modern retail, showcasing a range of fashion-inspired apparel and personal care products. The company is dedicated to supporting women's diverse needs through its numerous offerings including bras, lingerie, and activewear. With a significant market presence, VS&Co...

Continue Reading
Athira Pharma's Exciting 10-for-1 Reverse Stock Split Announced

Updated Category News Views 128

Athira Pharma's Reverse Stock Split Announcement Athira Pharma, Inc., a clinical-stage biopharmaceutical company focused on innovative treatments for neurodegeneration, recently made headlines with its announcement of a 10-for-1 reverse stock split. This strategic move, supported by the company's stockholders, aims to adjust the market perception and performance of its...

Continue Reading
TEGNA Appoints John Treviño as WKYC President and GM

Updated Category News Views 134

TEGNA's Strategic Leadership Move at WKYC TEGNA Inc. (NYSE: TGNA) has made a significant announcement regarding the leadership of WKYC, the NBC affiliate in Cleveland. John Treviño has been appointed as the station's new president and general manager, effective soon. This strategic decision underscores TEGNA's commitment to enhancing local broadcasting in the Cleveland...

Continue Reading
Alveolus Bio and Shilpa Medicare Partner for Innovative Therapies

Updated Category News Views 208

New Strategic Investment to Propel Alveolus Bio Forward Alveolus Bio, an innovative biotech firm focused on developing cutting-edge treatments targeting respiratory diseases, has recently secured a significant strategic investment from Shilpa Medicare. This collaboration aims to enhance the company’s pioneering work in pulmonary therapeutics. Founded by the esteemed Dr....

Continue Reading
AB Amber Grid Reports 2024 Financial Highlights and Outlook

Updated Category News Views 444

AB Amber Grid Financial Overview for 2024 AB Amber Grid, a key player in the energy sector, recently shared its operating results for the first nine months of 2024. Located in Vilnius, this company has been committed to delivering detailed financial information aligned with International Financial Reporting Standards. Revenue and Profit Trends In the first nine months of...

Continue Reading